Ben And Catherine Ivy Foundation is located in Scottsdale, AZ. The organization was established in 2007. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations.
For the year ending 12/2019, Ben And Catherine Ivy Foundation generated $13.0m in total revenue. This organization has experienced exceptional growth, as over the past 2 years, it has increased revenue by an average of 22.0% each year . All expenses for the organization totaled $9.2m during the year ending 12/2019. You can explore the organizations financials more deeply in the financial statements section below.
Since 2019, Ben And Catherine Ivy Foundation has awarded 20 individual grants totaling $7,574,767. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Catherine E Ivy President | 60 | $304,794 | |
Megan Edwards Treasurer | 1 | $0 | |
Stephanie Mcrae ESQ Secretary | 1 | $0 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $11,047 |
Interest on Savings | $1,146,779 |
Dividends & Interest | $4,811,801 |
Net Rental Income | $60,680 |
Net Gain on Sale of Assets | $6,869,996 |
Capital Gain Net Income | $6,869,996 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $75,069 |
Total Revenue | $12,975,372 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $313,266 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $12,659 |
Interest | $0 |
Taxes | $361,227 |
Depreciation | $4,888 |
Occupancy | $77,415 |
Travel, conferences, and meetings | $38,107 |
Printing and publications | $9,158 |
Other expenses | $163,052 |
Total operating and administrative expenses | $1,672,136 |
Contributions, gifts, grants paid | $7,574,767 |
Total expenses and disbursements | $9,246,903 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $61,802,092 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $0 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Investments - land, buildings, equipment | $2,296,477 |
Investments—mortgage loans | $0 |
Investments—other | $238,127,991 |
Net Land, buildings, and equipment | $21,682 |
Other assets | $3,203 |
Total assets | $302,350,252 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $9,207 |
Total liabilities | $9,207 |
Over the last fiscal year, Ben And Catherine Ivy Foundation has awarded $7,574,767 in support to 20 organizations.
Grant Recipient | Amount |
---|---|
NEURO TRIALS LLC PURPOSE: MULTIPLE AWARDS:1) DEVELOPMENT FO TRIPLE-DRUG COCKTAILS TO INDUCE GLIOBLASTOMA.2) UCSF PRECLINICAL CORE FOR DRUG DEVELOPMENT AT THE IVY BRAIN TUMOR CENTER.3)10 YEAR IBTC GRANT4) MATCHING FUNDS NATIONAL GBM DAY | $4,317,325 |
STANFORD UNIVERSITY PURPOSE: YEAR 1 OF 3 YEAR AWARD: IMAGING TUMOR METABOLISM IN GBM PATIENTS TO HELP OPTIMIZE ANTI-TUMOR THERAPIES. THE ABILITY TO MONITOR PKM2, A KEY REGULATOR OF GBM METABOLISM, ALLOWS POTENIAL MONITORING ESSENTIAL TO EARLY THERAPY RESPONSE. | $1,024,920 |
Duarte, CA PURPOSE: YEAR 2 OF 3 YEAR AWARD:ENGINEERING DE NOVO ANTITUMOR IMMUNITY USING PATIENT-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS. DEVELOPMENT OF A NEW CLASS OF CARS EXPLOITING THE BROAD AND SELECTIVE GBM BINDING PROPERTIES OF THE SCORPION TOXIN PEPTIDE CHLOROTOXIN (CTX) AND EVALUATE THE POTENTIAL OF A CTX-CAR TO LIMIT GBM ANTIGEN ESCAPE. | $957,527 |
Rochester, MN PURPOSE: YEAR 4 OF 4 YEAR AWARD:AIM TO DRIVE CLINICAL DISCOVERY THROUGH OPTIMIZED MATHEMATICAL NEURO-ONCOLOGY RESPONSE METRICS BY CONNECTING PATIENT-SPECIFIC TREATMENT RESPONSE TO PATIENT SPECIFIC BENEFIT. | $500,000 |
SWEDISH MEDICAL CENTER PURPOSE: FINAL PAYMENT THERAPEUTIC TARGETING OF MICROENVIRONMENTS WHICH WILL LEVERAGE THE IVY GLIOBLASTOMA ATLAS PROJECT TO IDENTIFY CANCER STEM CELL AND IMMUNE CELL COMPARTMENTS AND TO FUNCTIONALLY CHARACTERIZE AND TARGET THE CELLS IN THE CONTEXT OF THEIR MICROENVIRONMENTS. | $413,000 |
DAMON RUNYON CANCER RESEARCH FDN PURPOSE: INVESTIGATION OF A BIOMARKER PHASE 2 STUDY TO EVALUATE TARGETED THERAPY HARBORING SPECIFIC GENETIC ALTERATIONS. | $200,000 |
Organization Name | Assets | Revenue |
---|---|---|
Mimi And Peter Haas Fund San Francisco, CA | $0 | $22,825,724 |
Meridian Institute Dillon, CO | $18,119,345 | $21,383,160 |
Gill Foundation Denver, CO | $227,109,663 | $12,646,667 |
William K Bowes Jr Foundation San Francisco, CA | $0 | $15,233,813 |
Walter And Elise Haas Fund San Francisco, CA | $290,773,419 | $45,613,238 |
Lisa And Douglas Goldman Fund San Francisco, CA | $314,443,125 | $25,968,602 |
Wood-Claeyssens Foundation Santa Barbara, CA | $112,450,224 | $19,490,467 |
The Saban Family Foundation Los Angeles, CA | $4,126,107 | $4,076,196 |
Freeport-Mcmoran Copper & Gold Foundation Phoenix, AZ | $2,326,146 | $18,600,000 |
Carroll Petrie Foundation Santa Fe, NM | $306,631,944 | $55,176,464 |
California Winegrowers Foundation Napa, CA | $3,681,527 | $16,676,626 |
Multi-Union Security Trust Fund Glendale, CA | $14,944,884 | $16,888,135 |